James Cummings
Chief Tech/Sci/R&D Officer at VAXART, INC.
Net worth: 424 841 $ as of 2024-03-30
Profile
James F.
Cummings is currently the Chief Medical Officer at Vaxart, Inc. Prior to this, he served as the President & CEO at ICON Government & Public Health Solutions, Inc. from 2018 to 2021.
He also held positions as Director at OyaGen, Inc., Director-Translational Medicine at Walter Reed Army Institute of Research from 2007 to 2009, Director-Defense Department at Global Emerging Infectious Surveillance & Response System from 2012 to 2015, and VP-Clinical Development & Translational Medicine at Novavax, Inc. from 2015 to 2018.
Cummings received his undergraduate degree from Georgetown University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXART, INC.
0.19% | 2024-03-27 | 326,801 ( 0.19% ) | 424 841 $ | 2024-03-30 |
James Cummings active positions
| Companies | Position | Start |
|---|---|---|
| VAXART, INC. | Chief Tech/Sci/R&D Officer | 2021-09-26 |
Former positions of James Cummings
| Companies | Position | End |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Government & Public Health Solutions, Inc. operates as a full service Contract Research Organization (CRO) specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. Its services include project, program, and data management; clinical monitoring; regulatory and medical affairs; and safety oversight and pharmacovigilance. The company was founded by Victoria Tifft in 1994 and is headquartered in Hinckley, OH. | Chief Executive Officer | 2021-08-31 |
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
| Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 2015-07-31 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | 2009-02-28 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology OyaGen, Inc. operates as a biotechnology company. It offers anti Human Immunodeficiency Virus (HIV) drug that solves the problems of viral resistance. The company was founded by Harold Smith in September 2003 and is headquartered in Henrietta, NY. | Director/Board Member | - |
Training of James Cummings
| Georgetown University School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| VAXART, INC. | Health Technology |
| Private companies | 4 |
|---|---|
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology OyaGen, Inc. operates as a biotechnology company. It offers anti Human Immunodeficiency Virus (HIV) drug that solves the problems of viral resistance. The company was founded by Harold Smith in September 2003 and is headquartered in Henrietta, NY. | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Government & Public Health Solutions, Inc. operates as a full service Contract Research Organization (CRO) specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. Its services include project, program, and data management; clinical monitoring; regulatory and medical affairs; and safety oversight and pharmacovigilance. The company was founded by Victoria Tifft in 1994 and is headquartered in Hinckley, OH. | Commercial Services |
| Walter Reed Army Institute of Research | |
| Global Emerging Infectious Surveillance & Response System |
- Stock Market
- Insiders
- James Cummings
